High prevalence of significant liver fibrosis and cirrhosis in chronic hepatitis B patients with normal ALT in central Europe-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

High prevalence of significant liver fibrosis and cirrhosis in chronic hepatitis B patients with normal ALT in central Europe

Published:2011-04-18 Issue:6 Volume:83 Page:968-973
ISSN:0146-6615
Container-title:Journal of Medical Virology
language:en
Short-container-title:J. Med. Virol.

Author:

Göbel Thomas,Erhardt Andreas,Herwig Mathias,Poremba Christopher,Baldus Stephan Ernst,Sagir Abdurrahman,Heinzel-Pleines Ulrike,Häussinger Dieter

Publisher

Wiley

Subject

Infectious Diseases,Virology

Reference29 articles.

1. Impact of non-alcoholic fatty liver disease on chronic hepatitis B;Bondini;Liver Int,2007

2. Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level;Chen;JAMA,2006

3. Prophylaxis, diagnosis and therapy of hepatitis B virus (HBV) infection: The German guidelines for the management of HBV infection;Cornberg;Z Gastroenterol,2007

4. What is the reason of elevated alanine aminotransferase level in HBeAg negative patients with low viremia: NAFLD or chronic hepatitis;Demir;Ann Hepatol,2007

5. Classification of chronic hepatitis: Diagnosis, grading and staging;Desmet;Hepatology,1994

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Significant liver histological change is common in HBeAg-positive chronic hepatitis B with normal ALT;BMC Infectious Diseases;2024-07-23

2. Histological features of chronic hepatitis B patients with normal alanine aminotransferase according to different criteria;Hepatology Communications;2024-01

3. Significant liver histological change is not uncommon in ALT normal HBeAg-positive chronic hepatitis B;2023-10-06

4. The efficacy and safety of pegylated interferon α-2b-based immunotherapy for inactive hepatitis B surface antigen carriers;European Journal of Gastroenterology & Hepatology;2023-08-14

5. Cost-effectiveness of expanded antiviral treatment for chronic hepatitis B virus infection in China: an economic evaluation;The Lancet Regional Health - Western Pacific;2023-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3